ERICA YOUNG: Open Payments
NPI 1699016394 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 53 payments from 15 companies in 2025. Trend: 2023 $4,812 · 2024 $919 · 2025 $1,268
Food & beverage: $1,234Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $395 |
| GENZYME CORPORATION | 10 | $221 |
| CSL Behring | 7 | $147 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Amgen Inc. | 4 | $87 |
| GlaxoSmithKline, LLC. | 3 | $82 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
| Organon LLC | 1 | $27 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, Andembry, AYVAKIT, AIRSUPRA, TRELEGY ELLIPTA, Rhapsido.
Industry payments across IL — which companies pay providers there.
